|
Internet Drug News.com online since 1998 |
||
|
Pharmaceutical News Harvest |
||
5/17 Just a Fancy, Expensive Way to Identify Key Opinion Leaders
Pills Tracked From Doctor to Patient to Aid Drug Marketing .... One company, Activate Networks, assigned physicians a ranking based on how connected they were, which helped companies decide where to send a representative, or whom to invite to a talk about a drug .... [NY Times]
See also: Drug Marketers Use Social Network Diagrams to Help Locate Influential Doctors [NY Times graphic]
5/17 Moveable Starting Line Helps FDA Finish Early
Xofigo Approval: Three Months Early--Or Two Months Late? .... The new terms of the Prescription Drug User Fee Act performance goals that took effect in October give FDA an extra two months after an NDA is submitted before it is "officially" filed .... [The RPM Report/First Take ]
5/17 Drugmakers Rather Not Wade Into Social Media Fray
Pharmas are cool with YouTube but fear Twitter .... Respondents were most comfortable with YouTube (68% called it acceptable, update or no), followed by LinkedIn (62%) and Facebook (60%, even though many abandoned their brand pages on the site after comments were mandated). Respondents were twitchy about text messaging (49%), Twitter (42%) and Flickr (32%) .... [The RPM Report/First Take]
5/17 The Kids Are Not Alright
One in five U.S. kids has a mental health disorder, CDC reports .... "Boys are more likely than girls to have most of the disorders overall," said Ruth Perou, the team leader for child development studies at the CDC. .... [HealthDay]
5/17 After Just Five Weeks, Tecfidera Has Reached Half of Gilenya's Sales Level
Multiple sclerosis prescription data confirm warehousing effect for Biogen Idec's Tecfidera .... Although Biogen Idec's multiple sclerosis therapy Tecfidera has delivered an impressive performance since launching five weeks ago, total and new prescriptions for competing therapies have yet to decline. .... [First Word Pharma]
5/17 Worth a Click for the Declining Revenue Chart
Cheerleaders: Look Beyond Pharma For Jobs .... Widespread job cuts in the pharmaceutical industry result in part from loss of patent protection for formerly blockbuster drugs. That saps revenue growth and, as genrics displace a brand name drug, the need for a large sales force drops off sharply .... [First Word Pharma]
5/17 Roche May Have Found its Rituxan Replacement
Data show new Roche leukemia drug may improve on Rituxan .... The combination of obinutuzumab plus chemotherapy led to an 86 percent reduction in risk of disease progression, according to data from an ASCO abstract .... [Yahoo]
5/17 Forteo + Prolia = Strongest Bones
Combo Drug Therapy May Work Best to Strengthen Bones .... Bone density measured at the lumbar spine increased 6.2 percent with teriparatide alone and 5.5 percent with denosumab alone, but combination treatment resulted in a 9.1 percent increase .... [HealthDay]
5/17 A Look Down the Tracks at Drugs in Development for Alzheimers
Any Light at the End of the Tunnel for Alzheimer's Disease? .... While many researchers still think the amyloid hypothesis holds the most potential for treating Alzheimer's, a few companies are also now focusing on reducing tau tangles .... [Motley Fool]
5/17 Internet Drug News Fast Takes:
AstraZeneca Advances Three Cancer Drugs Into Late-Stage Trials
Bloomberg
Feces Contaminate More Than Half of U.S. Public Pools
Bloomberg
Novartis says has no intention of buying Actavis
Reuters
Sanofi recruits patients for arthritis trials
MedCity News
Through the Eyes of a Burglar: Study Provides Insights on Habits and Motivations
University of North Carolina at Charlotte
Pharmacist-Directed Anticoagulation Service Can Impact Patient Satisfaction
Henry Ford Health System
5/16 "Every single FDA inspector that went to India said they would never take a Ranbaxy drug…"
Dirty medicine .... The epic inside story of long-term criminal fraud at Ranbaxy, the Indian drug company that makes generic Lipitor for millions of Americans. .... [Fortune]
5/16 Xofigo OK'd for Advanced Prostate Cancer
Bayer, Algeta Win U.S. Approval for Prostate Cancer Drug .... The Food and Drug Administration cleared the medicine more than three months early for patients whose disease has spread to their bones .... [Bloomberg]
5/16 Simponi Now Approved for Ulcerative Colitis
FDA expands indication for Johnson & Johnson's Simponi for ulcerative colitis .... The expanded approval of the drug was based on two clinical studies demonstrating that the tumour necrosis factor-alpha inhibitor was associated with a higher clinical response rate than placebo .... [First Word Pharma]
5/16 A Physician/Behavioral Econ Expert Discusses if Women Will Take Breast Cancer Prevention Pills
Who Wants to Take a Pill to Prevent Breast Cancer? .... With this report on breast cancer prevention pills, the United States Preventive Services Taskforce has switched from rejecting something patients believed in to endorsing something most patients will reject .... [Forbes]
5/16 Another Try at at Cancer Vaccine Shows Promising Early Results
Gradalis's Fang Bares Its Teeth in Fighting Ovarian Cancer .... The mean time between starting treatment and cancer recurring for patients receiving the vaccine was 470 days, versus 193 days for patients receiving standard treatment .... [xconomy]
5/16 6% Headcount Cut at Astellas
Astellas shutters OSI and Perseid, lets 200 US staff go in R&D reorg .... As part of the shakeup, the company is shuttering two of its US subsidiaries — OSI, the Farmingdale, NY-based oncology firm (of Tarceva fame) it acquired for $4 billion in 2010, and Redwood, CA-based DNA shuffling specialist Perseid, on which Astellas exercised a buy-out option for $76 million in 2011 .... [MM&M]
5/16 Back Pain Pills Killing Function Up Front
Meds for Back Pain Tied to Higher Erectile Dysfunction Risk .... Long-term use of opioids was associated with greater use of medications for erectile dysfunction or testosterone replacement compared with no opioid use (odds ratio, 1.45). .... [HealthDay]
5/16 One Step Closer to Cloning People
Scientists Clone Human Embryos To Make Stem Cells .... The accomplishment is a long-sought step toward harnessing the potential power of embryonic stem cells to treat many human diseases. But the work also raises a host of ethical concerns .... [NPR]
5/16 Drug Research and Development Should Be Delinked from Manufacturing and Marketing
How Drug Companies Keep Medicine Out of Reach .... For almost a decade, the United States has been standing in the way of an idea that could lead to cures for some of the world's most devastating illnesses .... [The Atlantic]
5/16 Combination Therapies Latest Trend in Melanoma
Bristol-Myers Drug Cocktail Stymies Melanoma Tumors .... Tumors shrank in 40 percent of patients, and in 53 percent of those who got the most effective dose combination of Yervoy and experimental therapy nivolumab .... [Bloomberg]
5/16 Internet Drug News Fast Takes:
US Senate confirms Tavenner as Medicare/Medicaid chief
Reuters
Drug shortages persist despite federal efforts to stop them
Advisory Board
Warning didn't change for-profit dialysis drug use
Reuters Health
FDA approves genetic test for lung cancer drug
USA Today
Estimated Health Costs in Retirement Drop
NY Times
|
Site Map | Privacy Policy | Contact Webmaster | |
||